Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 1475 entries
View as:

Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT03504696 Org: User:
Start: 12/20/16 End: 02/20/18 Due: 02/20/19

A Study of BMS-986205 Given in Combination With Nivolumab in Patients With Advanced Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03192943 Org: User:
Start: 06/23/17 End: 12/11/18 Due: 12/11/19

Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00357188 Org: User:
Start: 07/31/06 End: 09/30/06 Due: 09/30/07

A Study to Assess the Drug-drug Interaction of BMS-963272 and Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT04124003 Org: User:
Start: 10/08/19 End: 01/03/20 Due: 01/03/21

Drug-Drug Interaction Study in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00904059 Org: User:
Start: 05/31/09 End: 07/31/09 Due: 07/31/10

A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00481247 Org: User:
Start: 09/30/07 End: 12/31/15 Due: 12/31/16

Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients

Phase: N/A Priority: Normal
NCT ID: NCT00124449 Org: User:
Start: 02/28/05 End: 04/30/08 Due: 04/30/09

UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01979939 Org: User:
Start: 12/31/13 End: 11/30/14 Due: 11/30/15

A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen

Phase: N/A Priority: Normal
NCT ID: NCT02066636 Org: User:
Start: 04/09/14 End: 10/06/21 Due: 10/06/22

Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin

Phase: N/A Priority: Normal
NCT ID: NCT00773344 Org: User:
Start: 12/31/05 End: 08/31/09 Due: 08/31/10

Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Phase: N/A Priority: Normal
NCT ID: NCT00944905 Org: User:
Start: 07/31/09 End: 11/30/12 Due: 11/30/13

Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)

Phase: N/A Priority: Normal
NCT ID: NCT01844518 Org: User:
Start: 08/30/13 End: 02/01/23 Due: 02/01/24

Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)

Phase: N/A Priority: Normal
NCT ID: NCT00256750 Org: User:
Start: 03/31/05 End: 04/30/15 Due: 04/30/16

Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin

Phase: N/A Priority: Normal
NCT ID: NCT02279732 Org: User:
Start: 10/13/14 End: 05/03/18 Due: 05/03/19

A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug

Phase: N/A Priority: Normal
NCT ID: NCT00382668 Org: User:
Start: 10/31/06 End: 08/31/07 Due: 08/31/08

A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02935634 Org: User:
Start: 11/29/16 End: 05/11/22 Due: 05/11/23

Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials

Phase: N/A Priority: Normal
NCT ID: NCT01428063 Org: User:
Start: 09/30/11 End: 12/31/14 Due: 12/31/15

Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC

Phase: N/A Priority: Normal
NCT ID: NCT00002057 Org: User:
Start: - End: - Due: -

Effectiveness of Dasatinib in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study

Phase: N/A Priority: Normal
NCT ID: NCT02389972 Org: User:
Start: 04/11/13 End: 07/13/17 Due: 07/13/18

Post-marketing Study Assessing the Long-Term Safety of Abatacept

Phase: N/A Priority: Normal
NCT ID: NCT02169544 Org: User:
Start: 01/31/14 End: 02/28/17 Due: 02/28/18

A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT00048568 Org: User:
Start: 12/31/02 End: 10/31/09 Due: 10/31/10

A Study of Nivolumab in Participants With Squamous Cell Carcinoma of the Head & Neck (SCCHN) - Patient Reported Outcomes (PRO)

Phase: N/A Priority: Normal
NCT ID: NCT05068609 Org: User:
Start: 08/13/20 End: 10/18/21 Due: 10/18/22

BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00207051 Org: User:
Start: 01/31/06 End: 12/31/08 Due: 12/31/09

UNITY 3: A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 in Subjects With Genotype 1 Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT02123654 Org: User:
Start: 04/30/14 End: 08/31/15 Due: 08/31/16

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of BMS-986278 and the Effects of BMS-986278 on Cardiac Repolarization in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06746402 Org: User:
Start: 02/10/25 End: 09/26/25 Due: 09/26/26